PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Feb-2024 Global Cloud-Based Drug Discovery Platform Industry to Achieve 12.6% CAGR, Poised at US$ 7,529.59 Million Valuation by 2032 | FMI Insights MARKITWIRED
01-Feb-2024 Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia Businesswire
01-Feb-2024 Multi Radiance Medical Breaks New Ground in Fibromyalgia Pain Relief with the First FDA-Cleared Therapeutic Laser Businesswire
01-Feb-2024 BGB Group Announces Partnership with Scrum50 to Deliver High-Impact, Consumer-Centric Creative to Healthcare Clients Businesswire
01-Feb-2024 Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February Businesswire
01-Feb-2024 Ingersoll Rand Acquires Friulair to Expand Air Treatment Capabilities Businesswire
01-Feb-2024 UroGen Pharma to Participate at Upcoming Investor Conferences Businesswire
01-Feb-2024 Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference Businesswire
01-Feb-2024 Synchron Acquires Equity Stake in ACQUANDAS Businesswire
01-Feb-2024 NextPoint Therapeutics Appoints Ivan Cheung as Chief Executive Officer Businesswire
01-Feb-2024 Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal Businesswire
01-Feb-2024 Novii+ Wireless Maternal and Fetal Monitoring Solution Cleared by the FDA for Monitoring Approximately 95% of All Eligible Births in the United States1 Businesswire
01-Feb-2024 Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists to Gather for the 2024 Tandem Meetings AccessWire
01-Feb-2024 2024 Resident of Distinction Award(TM) Recipients Recognized at Maui Derm Hawaii AccessWire
01-Feb-2024 Register Now for the 2024 MedDev eMarketing Summit (San Diego, CA, United States - May 22-23, 2024) - ResearchAndMarkets.com Businesswire
01-Feb-2024 RS Oncology Announces First Patient Dosed in Phase 2 Clinical Study (MITOPE) Investigating RSO-021 for the Treatment of Malignant Pleural Mesothelioma and Metastatic Disease to the Lung Businesswire
01-Feb-2024 Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024: Insights On 10 Current & Potential Proprietary Platforms, Company, Indication & Phase for 15 Drugs, and 14 Companies - ResearchAndMarkets.com Businesswire
01-Feb-2024 NeoGenomics Signs Working with Cancer Pledge in Support of Employees Businesswire
01-Feb-2024 Atlanta Dental Spa Wins Back-to-Back 'Best Cosmetic Dentist' Awards in 2024 AccessWire
01-Feb-2024 Deb Autor, Former FDA Deputy Commissioner, Appointed CEO of Healthcare Innovation Catalysts Businesswire